Overview
Cost and time pressure on the development of innovative bio-pharmaceuticals and the market introduction of several biosimilars push the industry to redesign processes and technologies. With the support of regulatory bodies continuous processing technology development and implementation is progressing rapidly.
Why should you Attend
To get an overview of the:
Latest continuous Bio-processing technologies
Stages of development
Implementation and
Impact on quality and costs
Areas Covered in the Session
Regulatory Background
Important Terminology
Overview of technology allowing continuous bio-processing
Process Development Considerations
Control Strategies
Case studies for process design and economical evaluation
Who Will Benefit
Managers & teams working on bio-pharmaceutical- or diagnostic production processes or as suppliers, in the following areas:
R &D
Production
Regulatory
Quality
Technology
Engineering
Senior management
Speaker Profile
Margit Holzer is a biochemical engineer with 25 years expertise in the development and implementation of biochemical/technological production processes. She holds a PhD in biotechnology from the University of Natural Resources and Applied Life Sciences in Vienna (Austria). Margit has worked all over Europe for Boehringer-Ingelheim and Novasep. She held various positions in R&D, manufacturing, quality, technology & engineering, including several executive positions such as Technology & Engineering Director.